QualityStocks would like to highlight Caliber Imaging & Diagnostics, Inc. (
OTCQB: LCDX), a medical technologies company that designs, develops, and markets innovative imaging solutions that shows tissue at the cellular level. The company is currently the only company in the world to offer in vivo confocal microscopes designed specifically for imaging skin and other tissue. Caliber I.D.’s Rapid Cell ID technology enables scientists and physicians to characterize intact normal and abnormal cellular architecture that is otherwise invisible to the naked eye.
In the company’s news,
Caliber Imaging & Diagnostics, formerly known as Lucid, Inc., has recruited Robert P. Fischmann to the newly created position of Vice President of Operations.
Chief Executive Officer of Caliber I.D., L. Michael Hone stated, “As we prepare for the anticipated growth of our company, we have reached the point where we will benefit from the expertise of an experienced, seasoned operations professional. I am honored that Robert Fischmann, with his substantial global and domestic experience, has accepted this role. Robert will report directly to me, and I am confident he will excel in overseeing the direction, strategy, planning and execution of our manufacturing operations activities.”
Fischmann is an executive with over three decades of experience in both operations and management roles within technically oriented product companies. He has held key positions between 1981 and 2011 of increasing responsibility at Eastman Kodak Company. Most recently, he served in the position of Director-Worldwide Operations and Customer Service & Vice President at Prepress Solutions. It was in that position that he oversaw all manufacturing operations, customer service engineering, as well as field technical assistance within Eastman Kodak’s $1.6B Prepress Solutions business. Fischmann earned a BS degree in mechanical engineering from Union College and an MS degree in manufacturing and engineering management from Clarkson University. He also holds an MBA from Rochester Institute of Technology.
Fischmann’s responsibilities at Caliber I.D. are set to include managing all of the company’s production control, production process development, purchasing, quality systems, shipping and receiving, customer support and FDA compliance activities. In addition he will collaborate with CEO Michael Hone on future innovations and manufacturing plans, as well as consult on product design for manufacturability.
Fischmann commented, “Caliber I.D.’s goal of advancing its confocal microscopy technology will require a streamlined manufacturing operations process that incorporates a firm knowledge of the life science market. With effective operations strategies in place, it is my belief that the Company will cement its reputation as a leader in its field. I look forward to serving as Vice President of Operations and working with the management team as the Company moves ahead.”
About QualityStocks
QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.
To sign up for The QualityStocks Daily Newsletter, please visit
www.QualityStocks.net
To connect with QualityStocks via Facebook, please visit http://Facebook.com/QualityStocksPage
To connect with QualityStocks via Twitter, please visit http://Twitter.com/QualityStocks
Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net
Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
